Elevated levels of NfL in cerebrospinal fluid and blood reflect active neurodegeneration and have been shown to correlate with brain atrophy, making it a valuable indicator of cognitive decline, especially in the early stages of MS [7], disease activity, progression, and treatment response in multiple sclerosis (MS) [8,9]. Here, NEFL is linked to myeloid sarcoma.